TACSTD2 and cancer: TACSTD2 overexpression has been reported in numerous human cancers, such as colorectal, ovarian, pancreatic, cervical, gastric, bile duct cancer and squamous cell carcinoma of the oral cavity, as compared with the corresponding normal tissue, and the expression level has been shown to correlate with the poor patient prognosis (10–16).